Congenital Heart Diseases (CHDs) | Comprehensive Nursing Care Plan for Congenital Heart Diseases (CHDs) |

 

Congenital Heart Diseases (CHDs)

Definition:
Congenital heart diseases (CHDs) refer to structural abnormalities or defects in the heart or great vessels present at birth. These defects may disrupt normal blood flow, oxygenation, and heart function, leading to a wide spectrum of clinical presentations. CHDs can range from simple defects that require no intervention to complex anomalies needing immediate medical or surgical management.


Topics in Detail:

1. Embryological Development of the Heart

Overview:
The heart is the first functional organ to develop during embryogenesis, beginning its formation at approximately 3 weeks of gestation and completing most of its development by the 8th week.

Stages of Heart Development:

  • Formation of Heart Tube ( Week 3):
    • The heart originates as a pair of endothelial heart tubes, which fuse to form a single primitive heart tube.
  • Looping (Week 4):
    • The tube folds and loops to create the atria, ventricles, and major vessels.
  • Septation (Weeks 5–8):
    • Formation of the atrial and ventricular septa separates the heart into four chambers.
    • The truncus arteriosus divides into the aorta and pulmonary trunk.
  • Valvular Formation:
    • Development of atrioventricular and semilunar valves ensures unidirectional blood flow.

Congenital Defects Originating During Development:

  • Failure of septation → Ventricular Septal Defect (VSD) or Atrial Septal Defect (ASD).
  • Improper looping → Transposition of Great Arteries (TGA).
  • Persistent truncus arteriosus → Single outflow tract instead of two.

2. Etiology of CHDs

Causes:

  • Genetic Factors:

    • Chromosomal abnormalities (e.g., Down syndrome, Turner syndrome).
    • Single-gene mutations or syndromes (e.g., Noonan syndrome).
  • Environmental Factors:

    • Maternal infections during pregnancy (e.g., rubella).
    • Exposure to teratogens (e.g., alcohol, drugs like lithium, and certain medications).
  • Multifactorial Inheritance:

    • Combination of genetic predisposition and environmental triggers.

3. Clinical Manifestations of CHDs

Cyanotic CHDs:

  • Cyanosis (bluish skin discoloration).
  • Hypoxemia and clubbing of fingers.
  • Failure to thrive.
  • Symptoms of heart failure (e.g., fatigue, poor feeding, and breathlessness).

Acyanotic CHDs:

  • Pulmonary congestion (tachypnea, wheezing).
  • Frequent respiratory infections.
  • Heart murmur on auscultation.
  • Growth retardation.

4. Diagnosis of CHDs

Diagnostic Tools:

  • History and Physical Examination:
    • Family history, cyanosis, murmurs, and failure to thrive.
  • Imaging Studies:
    • Chest X-ray: Heart size, pulmonary vascular markings.
    • Echocardiography: Primary tool for confirming structural defects.
  • Advanced Diagnostics:
    • Cardiac MRI/CT: Detailed imaging of anatomy.
    • Cardiac catheterization: Hemodynamic assessment and interventional treatment.

5. Prognosis of CHDs

  • Simple CHDs:
    • Often have excellent outcomes with or without treatment.
    • Examples: Small VSDs or ASDs may close spontaneously.
  • Complex CHDs:
    • Require timely surgical intervention and long-term follow-up.
    • Prognosis depends on the nature of the defect, timing of intervention, and comorbidities.

6. Pathophysiology of CHDs

  • Acyanotic CHDs:

    • Left-to-right shunts → Volume overload in pulmonary circulation → Pulmonary hypertension → Right heart strain.
    • Examples: VSD, ASD, Patent Ductus Arteriosus (PDA).
  • Cyanotic CHDs:

    • Right-to-left shunts → Mixing of oxygenated and deoxygenated blood → Systemic hypoxemia.
    • Examples: Tetralogy of Fallot (TOF), TGA.

7. Treatment Modalities of CHDs

Medical Management:

  • Symptom Control:

    • Diuretics, digoxin, ACE inhibitors for heart failure symptoms.
    • Prostaglandin E1 to maintain ductal patency in duct-dependent CHDs.
  • Non-Surgical Interventions:

    • Interventional cardiac catheterization (e.g., device closure of PDA or ASD).

Surgical Management:

  • Corrective surgery (e.g., arterial switch for TGA).
  • Palliative surgery (e.g., Blalock-Taussig shunt for TOF).

Supportive Therapy:

  • Nutritional support for growth failure.
  • Regular vaccinations to prevent infections.

8. Nursing Management of CHDs

  • Preoperative Care:

    • Monitor for signs of heart failure (tachycardia, fatigue).
    • Ensure adequate hydration and nutrition.
    • Educate parents about the defect and its management.
  • Postoperative Care:

    • Monitor for arrhythmias, infection, and wound healing.
    • Provide respiratory support as needed.
    • Pain management and psychological support for the child and family.
  • Long-Term Care:

    • Support adherence to medications and follow-up visits.
    • Promote developmental milestones and growth.
    • Educate on the importance of maintaining oral hygiene to prevent infective endocarditis.

Detailed Description of Congenital Heart Diseases

Congenital heart diseases (CHDs) are structural or functional abnormalities of the heart and great vessels present at birth. They can involve abnormal shunting, cyanosis, or obstructed blood flow. Below is a detailed explanation of each topic:


1. Tetralogy of Fallot (TOF)

  • Definition: A cyanotic heart defect consisting of four abnormalities: ventricular septal defect (VSD), pulmonary stenosis, right ventricular hypertrophy, and an overriding aorta.
  • Etiology: Genetic factors, maternal rubella, or environmental factors.
  • Clinical Manifestations: Cyanosis, "Tet spells" (cyanotic episodes), difficulty feeding, failure to thrive.
  • Diagnosis: Echocardiogram, chest X-ray (boot-shaped heart), cardiac catheterization.
  • Prognosis: Variable; improved with surgical intervention.
  • Pathophysiology: Obstruction of pulmonary blood flow causes right-to-left shunting through VSD, leading to cyanosis.
  • Treatment Modalities: Corrective surgery (e.g., intracardiac repair), beta-blockers for "Tet spells."
  • Nursing Management: Oxygen therapy, monitoring cyanosis, and post-surgical care.

2. Atrial Septal Defect (ASD)

  • Definition: An opening in the atrial septum allowing left-to-right shunting of blood.
  • Etiology: Genetic syndromes (e.g., Down syndrome).
  • Clinical Manifestations: Asymptomatic in mild cases, fatigue, shortness of breath, recurrent respiratory infections.
  • Diagnosis: Echocardiogram, ECG (right atrial enlargement).
  • Prognosis: Good with timely surgical closure.
  • Pathophysiology: Increased pulmonary blood flow leading to right atrial and ventricular overload.
  • Treatment Modalities: Catheter-based or surgical closure.
  • Nursing Management: Post-surgical monitoring and prevention of infection.

3. Ventricular Septal Defect (VSD)

  • Definition: A hole in the ventricular septum causing left-to-right shunting.
  • Etiology: Chromosomal abnormalities, maternal diabetes.
  • Clinical Manifestations: Heart murmur, growth retardation, congestive heart failure (CHF) symptoms.
  • Diagnosis: Echocardiogram, chest X-ray (cardiomegaly).
  • Prognosis: Excellent after repair; some small defects close spontaneously.
  • Pathophysiology: Increased pulmonary flow leads to pulmonary hypertension.
  • Treatment Modalities: Medical (diuretics, digoxin), surgical patch closure.
  • Nursing Management: Monitor CHF signs and manage feeding difficulties.

4. Eisenmenger’s Complex

  • Definition: Severe pulmonary hypertension due to longstanding left-to-right shunt reversing to right-to-left shunt.
  • Etiology: Unrepaired VSD, PDA, or ASD.
  • Clinical Manifestations: Cyanosis, clubbing, exercise intolerance, heart failure.
  • Diagnosis: Echocardiogram, right heart catheterization.
  • Prognosis: Poor; palliative measures only.
  • Pathophysiology: Chronic pulmonary hypertension damages pulmonary vessels.
  • Treatment Modalities: Pulmonary vasodilators, heart-lung transplantation.
  • Nursing Management: Avoid dehydration, infection, and monitor oxygenation.

5. Patent Ductus Arteriosus (PDA)

  • Definition: Persistence of the ductus arteriosus after birth, allowing blood to flow from the aorta to the pulmonary artery.
  • Etiology: Prematurity, maternal rubella infection.
  • Clinical Manifestations: Machinery-like murmur, bounding pulses, failure to thrive.
  • Diagnosis: Echocardiogram.
  • Prognosis: Excellent after closure.
  • Pathophysiology: Left-to-right shunting causes pulmonary overcirculation.
  • Treatment Modalities: Indomethacin, surgical or catheter closure.
  • Nursing Management: Monitor for CHF, administer medications.

6. AP Window

  • Definition: A communication between the ascending aorta and pulmonary artery.
  • Etiology: Failure of septation in fetal development.
  • Clinical Manifestations: Cyanosis, CHF, recurrent infections.
  • Diagnosis: Echocardiogram, cardiac MRI.
  • Prognosis: Improved with early surgical intervention.
  • Treatment Modalities: Surgical correction.
  • Nursing Management: Postoperative monitoring.

7. Truncus Arteriosus

  • Definition: A single arterial trunk supplies systemic, pulmonary, and coronary circulation.
  • Etiology: Failure of septation during embryogenesis.
  • Clinical Manifestations: Cyanosis, CHF symptoms.
  • Diagnosis: Echocardiogram, cardiac catheterization.
  • Prognosis: Variable; depends on surgical timing.
  • Pathophysiology: Mixed blood flow leads to cyanosis and overload.
  • Treatment Modalities: Surgical repair.
  • Nursing Management: Pre-surgery stabilization and post-surgery care.

8. Transposition of Great Arteries (TGA)

  • Definition: The aorta and pulmonary artery are switched, causing deoxygenated blood to circulate systemically.
  • Etiology: Unknown; possibly genetic.
  • Clinical Manifestations: Severe cyanosis, respiratory distress.
  • Diagnosis: Echocardiogram, cardiac catheterization.
  • Prognosis: Excellent with surgical correction.
  • Pathophysiology: Parallel circulation systems; survival depends on a PDA or septal defect.
  • Treatment Modalities: Prostaglandins to maintain PDA, arterial switch surgery.
  • Nursing Management: Pre-surgery oxygenation, post-surgery ICU care.

9. Pulmonary Stenosis/Atresia

  • Definition: Narrowing/absence of the pulmonary valve.
  • Etiology: Genetic mutations, congenital syndromes.
  • Clinical Manifestations: Cyanosis, exercise intolerance.
  • Diagnosis: Echocardiogram, ECG.
  • Prognosis: Variable; good with intervention.
  • Pathophysiology: Obstruction increases right ventricular pressure.
  • Treatment Modalities: Balloon valvuloplasty, surgical repair.
  • Nursing Management: Monitor oxygenation, prepare for interventions.

10. Coarctation of Aorta

  • Definition: Narrowing of the aorta.
  • Etiology: Genetic syndromes (e.g., Turner syndrome).
  • Clinical Manifestations: High BP in upper limbs, weak pulses in lower limbs.
  • Diagnosis: Echocardiogram, MRI.
  • Prognosis: Good with surgical repair.
  • Pathophysiology: Obstruction leads to LV hypertrophy.
  • Treatment Modalities: Balloon angioplasty, surgical resection.
  • Nursing Management: Monitor BP, post-surgical care.

11. Ebstein’s Anomaly

  • Definition: Malformation of the tricuspid valve.
  • Etiology: Maternal lithium use.
  • Clinical Manifestations: Cyanosis, CHF, arrhythmias.
  • Diagnosis: Echocardiogram.
  • Prognosis: Depends on severity.
  • Treatment Modalities: Medical management, valve repair.
  • Nursing Management: Monitor cyanosis, manage CHF.

12. Double Outlet Right Ventricle (DORV), Single Ventricle, Hypoplastic Left Heart Syndrome (HLHS)

  • Definition: Severe structural abnormalities with improper ventricle development.
  • Etiology: Chromosomal defects.
  • Clinical Manifestations: Severe cyanosis, CHF.
  • Diagnosis: Echocardiogram.
  • Prognosis: Poor without surgical intervention.
  • Treatment Modalities: Staged surgeries (e.g., Norwood procedure for HLHS).
  • Nursing Management: ICU care, parental support.

Nursing Care Plan for Congenital Heart Diseases (CHDs)

Nursing Diagnosis

Goal / Objective

Nursing Interventions

Rationale

Evaluation

1. Decreased Cardiac Output related to structural heart defect affecting blood flow

To maintain adequate cardiac output as evidenced by normal heart rate, BP, capillary refill, and activity tolerance

- Monitor vital signs (HR, BP, RR, oxygen saturation) regularly.
- Assess heart sounds for murmurs or abnormal rhythms.
- Administer prescribed cardiac medications (e.g., digoxin, diuretics) as ordered.
- Maintain fluid balance; monitor intake and output.
- Position infant in semi-Fowler’s position to decrease cardiac workload.

To detect changes indicating compromised cardiac function and reduce strain on the heart.

Cardiac output is maintained within normal limits; no signs of cyanosis, fatigue, or tachycardia.

2. Ineffective Breathing Pattern related to pulmonary congestion secondary to heart defect

To promote effective breathing pattern and adequate oxygenation

- Assess respiratory rate, effort, and breath sounds.
- Administer supplemental oxygen as prescribed.
- Maintain airway patency; position child to facilitate lung expansion.
- Suction as needed.
- Provide calm environment to reduce oxygen demand.

To ensure adequate ventilation and reduce hypoxia due to increased pulmonary blood flow.

Child maintains normal respiratory rate and effort; oxygen saturation >95%.

3. Imbalanced Nutrition: Less than Body Requirements related to fatigue and increased metabolic demands

To achieve adequate nutritional intake and maintain ideal body weight

- Provide small, frequent, high-calorie feeds.
- Allow rest before and after feeding.
- Use gavage feeding if oral intake inadequate.
- Monitor weight daily and assess feeding tolerance.
- Encourage breastfeeding if possible.

Frequent rest prevents fatigue, while high-calorie intake supports growth and repair.

Child gains weight appropriately; shows improved feeding tolerance.

4. Activity Intolerance related to decreased oxygen supply and fatigue

To enable child to participate in age-appropriate activities without excessive fatigue

- Plan rest periods between activities.
- Cluster nursing care to allow uninterrupted rest.
- Monitor response to activity (vitals, cyanosis, dyspnea).
- Encourage quiet play to minimize exertion.

Reduces cardiac workload and conserves energy.

Child tolerates activity without dyspnea or fatigue.

5. Anxiety (parents/caregivers) related to child’s condition and prognosis

To reduce parental anxiety and enhance coping skills

- Provide clear explanations about disease, treatment, and prognosis.
- Encourage expression of fears and questions.
- Offer emotional support and involve parents in care.
- Refer to counseling or support groups if needed.

Education and emotional support promote understanding and coping.

Parents verbalize reduced anxiety and demonstrate effective coping strategies.

6. Risk for Infection related to invasive procedures or decreased immunity

To prevent infection and promote healing

- Maintain aseptic technique during procedures.
- Encourage good hand hygiene.
- Monitor temperature and WBC count.
- Limit exposure to sick visitors.
- Administer prophylactic antibiotics as ordered (especially before dental procedures).

Prevents infection which can worsen cardiac condition.

No signs of infection observed; normal temperature and WBC.


🩺 General Health Teaching / Discharge Planning

  • Educate parents about medication administration and side effects.
  • Teach signs of worsening heart failure (cyanosis, difficulty breathing, poor feeding).
  • Stress the importance of regular follow-up with cardiologist.
  • Encourage balanced diet and appropriate physical activity as tolerated.
  • Discuss endocarditis prophylaxis before surgeries or dental procedures.

 


Congenital Defect Assessment Tool

Congenital Defect Assessment Tool

Early screening tool for potential congenital anomalies in newborns and infants (2024 Guidelines)

Basic Information

Physical Characteristics

Functional Assessment

Family & Pregnancy History

Assessment Results

Important Disclaimer

This congenital defect assessment tool is designed for informational purposes only and is based on general screening guidelines. It is not a diagnostic tool and should not replace professional medical evaluation.

Key Limitations:

  • This tool cannot detect all congenital conditions
  • Some conditions may develop or become apparent later in childhood
  • Normal screening does not guarantee absence of congenital conditions
  • Genetic and metabolic disorders may not be identified by this screening

If you have any concerns about your child's development:

  • Consult your pediatrician immediately
  • For emergencies, seek immediate medical attention
  • Consider genetic counseling if family history is present

This tool does not store any personal health information. All assessments are performed locally in your browser.

Comments